Robert Gabbay M.D., Ph.D.

Robert A. Gabbay, M.D., Ph.D., has over 35 years of clinical and research experience and is Chief Medical Officer and Senior Vice President at Joslin Diabetes Center, Harvard Medical School. His research focuses on improving primary care health care delivery to enhance diabetes outcomes and patients' experiences. Dr. Gabbay has received funding from NIDDK, Agency for Healthcare Research and Quality (AHRQ), and the Center for Medicare and Medicaid Innovation for his care transformation work. Dr. Gabbay completed his Bachelor's Degree at McGill University and his PhD in Biochemistry from the University of Wisconsin.  He subsequently received his medical degree from The State University of New York at Brooklyn School of Medicine with a residency in internal Medicine at New York Hospital- Cornell and fellowship in Endocrinology, Diabetes and Metabolism at a joint Joslin- Beth Israel deaconess- Brigham and Women's Hospital program.

Dr. Gabbay's focus at Joslin Diabetes Center is to foster innovation within the walls of Joslin, as well as disseminating these approaches regionally, nationally, and internationally. He is dedicated to creating a model for the Patient-Centered Medical Neighborhood for diabetes, a compliment to his PCMH research.  Dr. Gabbay has led one of the first medical home pilots across 150 practices and 80,000 patients with diabetes. His interventions include behavior change using motivational interviewing, self-management support, decision support, technology, population health, medical neighborhood, digital health, and care management. The medical neighborhood will ensure patient centered coordinated care between the team of health professionals that are required to meet the patient's needs. Ultimately his focus has been to identify system gaps in care delivery and identify solutions to better coordinate care and optimize outcomes.

Dr. Gabbay is committed to providing the best quality possible to our diabetes patients while exceeding the highest national clinical quality measures. Through these innovative care delivery models – the Joslin is committed to providing solutions to providers, health systems, payer, governmental agencies or employers ultimately to improve the lives of those with diabetes.